Search results
Here is What to Know Beyond Why Catalyst Pharmaceuticals, Inc. (CPRX) is a Trending Stock
Zacks via Yahoo Finance· 1 year agoCatalyst (CPRX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Catalyst (CPRX) Stock Jumps 10%: Will It Continue to Soar?
Zacks via Yahoo Finance· 2 years agoCatalyst (CPRX) saw its shares surge in the last session with trading volume being higher than...
Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term
Zacks via Yahoo Finance· 3 months agoIt doesn't matter your age or experience: taking full advantage of the stock market and investing...
Catalyst Pharmaceutical (CPRX) Outpaces Stock Market Gains: What You Should Know
Zacks via Yahoo Finance· 1 year agoCatalyst Pharmaceutical (CPRX) closed at $15.38 in the latest trading session, marking a +0.79% move...
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Is Going Strong: Is the Market Following...
Simply Wall St. via Yahoo Finance· 2 years agoCatalyst Pharmaceuticals (NASDAQ:CPRX) has had a great run on the share market with its stock up by...
Here's Why Catalyst Pharmaceutical (CPRX) is a Great Momentum Stock to Buy
Zacks via Yahoo Finance· 2 years agoMomentum investing is all about the idea of following a stock's recent trend, which can be in either...
IBD Stock Of The Day Catalyst Pharma Is Hinting At An Acquisition — Why The Timing Is Perfect
Investor's Business Daily· 1 year agoCatalyst Pharmaceuticals is the IBD Stock Of The Day. After the biotech company reported its fourth...
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) high institutional ownership speaks for itself as...
Simply Wall St. via Yahoo Finance· 12 months agoKey Insights Institutions' substantial holdings in Catalyst Pharmaceuticals implies that they have...
Catalyst (CPRX) Q3 Earnings Miss, Sales Top, '23 View Up
Zacks via Yahoo Finance· 6 months agoCatalyst (CPRX) reports mixed third-quarter results. Firdapse and Fycompa sales continue to boost...
Catalyst CEO Says 'We Hit The Ball Out Of The Park,' But Shares Of IBD 50 Stock Crash
Investor's Business Daily· 12 months agoCatalyst Pharmaceuticals "hit the ball out of the park" in the first quarter, says Chief Executive...